Cases & Deals

Celgene files patent infringement suit against Barr Labs over generic version of ADHD drug Focalin XR®

Clients Celgene Corporation

Jones Day represented Celgene Corporation in a Hatch-Waxman patent infringement action against Barr Laboratories involving Celgene's drug Focalin XR® which is prescribed for the treatment of ADHD. The matter concluded through a mutually agreeable settlement.

Celgene Corporation, et al. v. Barr Laboratories, Inc., Case No. 3-07-cv-05552 (D.N.J.) (Judge Wolfson)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.